High-throughput Cell Analysis System Tender, USA - 106332175

Procurement Summary

Country : USA

Summary : High-throughput Cell Analysis System

Deadline : 30 Aug 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 106332175

Document Ref. No. : 75N95024Q00433

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; Quotes are being requested and a separate written solicitation will not be issued.

The solicitation number is 75N95024Q00433 and the solicitation is issued as request for quotation (RFQ).

This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Items and is not expected to exceed the simplified acquisition threshold.

The NeuroTherapeutics Development Unit (NTDU) Translational Neuroscience (TNC) National Institute of Neurological Disorders and Stroke (NINDS) requires the purchase of a high throughput cell analysis system with equivalent capabilities to the Agilent xCELLigence RTCA HT system to facilitate the screening and evaluation of toxicities to neurons and other cells following exposure to chemotoxic agents, toxic proteins and viral infections.

The mission of the Translational Neuroscience Center, TNC/ Neurotherapeutic Development Unit (NTDU), is to identify, characterize and develop new therapeutic agents to treat neuro degeneration and infectious diseases in the human brain. Currently NTDU utilizes many modalities to develop new therapeutic agents, many of the models involve cell toxicity and different assays to determine the toxic activity of chemicals, proteins and viral infections. A novel approach is to incorporate the real time cell analysis provided by the xCELLigence RTCA HT system to facilitate compound screening in 384 well plate format. High-throughput real-time cell analysis is ideal for screening viral mediated cytopathic effects (CPE), neutralizing antibodies, antibody-dependent cytotox...
Active Contract Opportunity
Notice ID : 75N95024Q00433
Related Notice : 75N95024Q00433
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office: NATIONAL INSTITUTES OF HEALTH NIDA
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Aug 26, 2024 03:55 pm EDT
Original Date Offers Due: Aug 30, 2024 02:00 pm EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Sep 14, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6640 - LABORATORY EQUIPMENT AND SUPPLIES
NAICS Code: 334516 - Analytical Laboratory Instrument Manufacturing

Place of Performance:

Documents

 Tender Notice

RFQ.pdf